Risk of carditis after three doses of vaccination with mRNA (BNT162b2) or inactivated (CoronaVac) covid-19 vaccination: a self-controlled cases series and a case–control study

BACKGROUND: Large-scale comparative research exploring the risk after the third dose and after inactivated covid-19 vaccination is limited. This study aimed to assess the risk of carditis following three doses of BNT162b2 or CoronaVac. METHODS: We conducted a self-controlled case series (SCCS) and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Min, Lai, Francisco Tsz Tsun, Cheng, Franco Wing Tak, Tsie, Natalie Tsz Ying, Li, Xue, Wan, Eric Yuk Fai, Wong, Carlos King Ho, Chan, Esther Wai Yin, Yiu, Kai Hang, Wong, Ian Chi Kei, Chui, Celine Sze Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039395/
https://www.ncbi.nlm.nih.gov/pubmed/37360861
http://dx.doi.org/10.1016/j.lanwpc.2023.100745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039395/
https://www.ncbi.nlm.nih.gov/pubmed/37360861
http://dx.doi.org/10.1016/j.lanwpc.2023.100745

Ejemplares similares